ECM
AMGN icon

ETrade Capital Management’s Amgen AMGN Stock Holding History

ETrade Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$4.98M Sell
19,595
-538
-3% -$133K 0.09% 109
2020
Q2 		$4.75M Buy
20,133
+5,716
+40% +$1.3M 0.1% 103
2020
Q1 		$2.92M Sell
14,417
-1,003
-7% -$219K 0.07% 141
2019
Q4 		$3.72M Buy
15,420
+4,269
+38% +$941K 0.08% 132
2019
Q3 		$2.16M Sell
11,151
-916
-8% -$176K 0.05% 204
2019
Q2 		$2.22M Buy
12,067
+1,036
+9% +$186K 0.06% 197
2019
Q1 		$2.1M Sell
11,031
-88
-0.8% -$16.8K 0.06% 193
2018
Q4 		$2.17M Buy
11,119
+174
+2% +$33.9K 0.07% 162
2018
Q3 		$2.27M Buy
10,945
+70
+0.6% +$13.8K 0.07% 176
2018
Q2 		$2.01M Buy
10,875
+428
+4% +$75.7K 0.06% 183
2018
Q1 		$1.78M Sell
10,447
-1,111
-10% -$204K 0.06% 198
2017
Q4 		$2.01M Buy
11,558
+609
+6% +$108K 0.06% 178
2017
Q3 		$2.04M Buy
10,949
+1,155
+12% +$205K 0.07% 166
2017
Q2 		$1.69M Buy
9,794
+791
+9% +$129K 0.07% 178
2017
Q1 		$1.48M Buy
9,003
+1,519
+20% +$252K 0.06% 186
2016
Q4 		$1.09M Buy
7,484
+737
+11% +$111K 0.05% 212
2016
Q3 		$1.13M Sell
6,747
-170
-2% -$28.7K 0.05% 200
2016
Q2 		$1.05M Sell
6,917
-95
-1% -$14.8K 0.06% 205
2016
Q1 		$1.05M Buy
7,012
+3,000
+75% +$446K 0.06% 192
2015
Q4 		$651K Sell
4,012
-228
-5% -$35.8K 0.04% 280
2015
Q3 		$586K Buy
4,240
+994
+31% +$157K 0.04% 280
2015
Q2 		$498K Buy
3,246
+71
+2% +$11.4K 0.03% 295
2015
Q1 		$508K Buy
3,175
+312
+11% +$49.1K 0.03% 286
2014
Q4 		$456K Buy
2,863
+437
+18% +$68.1K 0.03% 325
2014
Q3 		$341K Buy
2,426
+238
+11% +$31.1K 0.02% 342
2014
Q2 		$259K Buy
2,188
+884
+68% +$102K 0.02% 335
2014
Q1 		$161K Buy
1,304
+482
+59% +$58.5K 0.01% 349
2013
Q4 		$94K Sell
822
-236
-22% -$26.8K 0.01% 385
2013
Q3 		$118K Buy
1,058
+139
+15% +$15.1K 0.01% 325
2013
Q2 		$91K Buy
+919
New +$95.4K 0.01% 325

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ETrade Capital Management's AMGN Position: Q3 2020 in Review

ETrade Capital Management reduced its Amgen (AMGN) stake by 2.7% in Q3 2020, selling an estimated $133K and leaving 19,595 shares worth $4.98M. The position accounts for 0.09% of the portfolio, ranked #109.

ETrade Capital Management first reported a position in AMGN in Q2 2013 and has held it in 30 quarters since. 2,127 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

  • ETrade Capital Management held 19,595 shares of Amgen worth $4.98M as of Q3 2020.
  • ETrade Capital Management sold 538 Amgen shares in Q3 2020, an estimated $133K.
  • Amgen made up 0.09% of ETrade Capital Management's portfolio in Q3 2020, its #109 holding.
  • ETrade Capital Management first reported a position in Amgen in Q2 2013 and has held it in 30 quarters since.
  • 2,127 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.